Patient Advocacy Groups: A Vital Partner For Sponsors That Understand How To Engage With Patients

Julie, with over 25 years in patient advocacy for chronic diseases, emphasizes engaging patient advocacy groups (PAGs) at Parexel to enhance clinical trial experiences. PAGs serve as crucial sources of patient-centric insights and support, impacting drug development positively. They advocate for ethical research, faster treatment approvals, and improved patient care globally. Effective engagement with PAGs is not just about recruitment but building long-term partnerships based on mutual respect and shared goals. This involves understanding PAG missions, aligning objectives, and collaborating throughout the drug development lifecycle — from study design and recruitment to post-approval stages.

Parexel’s dedicated PAG engagement services foster collaborations with organizations like the National Health Council and Global Genes, ensuring trials meet patient needs and enhance clinical outcomes. Discover how strategic partnerships with PAGs can optimize clinical trials by accessing the full article below.